<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu Y</submitter><funding>Chinese Academy of Sciences</funding><funding>Science and Technology Commission of Shanghai Municipality</funding><funding>National Natural Science Foundation of China</funding><funding>Youth Innovation Promotion Association of the Chinese Academy of Sciences</funding><pagination>7763-7769</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8188586</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(22)</volume><pubmed_abstract>The extraordinarily rapid growth of malignant tumors depends heavily on the glucose metabolism by the pathways of glycolysis and mitochondrial oxidative phosphorylation to generate adenosine 5'-triphosphate (ATP) for maintaining cell proliferation and tumor growth. This study reports a tumor chemical suffocation therapeutic strategy by concurrently suppressing both glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) &lt;i>via&lt;/i> the co-deliveries of EDTA and rotenone into a glutathione (GSH)-overexpressed tumor microenvironment. EDTA is to block the glycolytic pathway through inhibiting the activity of glycolytic enzymes &lt;i>via&lt;/i> the chelation of magnesium ion, a co-worker of glycolytic enzymes, despite the presence of Ca&lt;sup>2+&lt;/sup>. Meanwhile rotenone is to inhibit the mitoc</pubmed_abstract><journal>Chemical science</journal><pubmed_title>Tumor chemical suffocation therapy by dual respiratory inhibitions.</pubmed_title><pmcid>PMC8188586</pmcid><funding_grant_id>ZDBS-LY-SLH029</funding_grant_id><funding_grant_id>2019</funding_grant_id><funding_grant_id>No. 21835007</funding_grant_id><funding_grant_id>No. 52072394</funding_grant_id><funding_grant_id>19QA1410100</funding_grant_id><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Ni D</pubmed_authors><pubmed_authors>Shi J</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors><pubmed_authors>Hu P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tumor chemical suffocation therapy by dual respiratory inhibitions.</name><description>The extraordinarily rapid growth of malignant tumors depends heavily on the glucose metabolism by the pathways of glycolysis and mitochondrial oxidative phosphorylation to generate adenosine 5'-triphosphate (ATP) for maintaining cell proliferation and tumor growth. This study reports a tumor chemical suffocation therapeutic strategy by concurrently suppressing both glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) &lt;i>via&lt;/i> the co-deliveries of EDTA and rotenone into a glutathione (GSH)-overexpressed tumor microenvironment. EDTA is to block the glycolytic pathway through inhibiting the activity of glycolytic enzymes &lt;i>via&lt;/i> the chelation of magnesium ion, a co-worker of glycolytic enzymes, despite the presence of Ca&lt;sup>2+&lt;/sup>. Meanwhile rotenone is to inhibit the mitoc</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2025-06-01T02:31:08.697Z</modification><creation>2025-06-01T02:31:08.697Z</creation></dates><accession>S-EPMC8188586</accession><cross_references><pubmed>34168829</pubmed><doi>10.1039/d1sc00929j</doi></cross_references></HashMap>